TCF7L2 Variants Are Associated with Increased Proinsulin/Insulin Ratios but Not Obesity Traits in the Framingham Heart Study. Diabetologia, vol
Coming on the heels of FDA approval in December, Axios reports that one analyst -- David Risinger of Leerink -- has called the rollout the fastest drug launch ever. This uptake is over twice that of any prior anti-obesity drug launch in the U.S., Novo Nordisk Executive Vice President U.S
In this study, human umbilical vein endothelial cells (HUVECs), exposed to palmitic acid (PA) to induce endothelial dysfunction, were incubated with metformin, liraglutide or their combination
Background and aims: Obesity and diabetes continue to be significant health challenges, even among the very young
found that the use of GLP-1RAs in diabetic patients might not increase the risk of new thyroid tumors in patients with T2MD (208)